# A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria

> **NCT06295302** · PHASE2 · UNKNOWN · sponsor: **Hubei Biological Medicine Industrial Technology Institute Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **DRUG:** HWH486
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06295302
- **Lead sponsor:** Hubei Biological Medicine Industrial Technology Institute Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-13
- **Primary completion:** 2025-12
- **Final completion:** 2026-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06295302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06295302, "A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06295302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*